U.S. Chemicals Stock News

Recent performance snapshot Paymentus Holdings (PAY) has drawn investor attention after a period of mixed share performance, with the stock up about 1% over the past day but down around 15% over the past month. Over the past 3 months the stock is lower by roughly 8%, and it is also down around 41% over the past year, while the company reports annual revenue of about US$1.28b and net income of US$74.01m. See our latest analysis for Paymentus Holdings. With the share price at US$23.49, the...

In May 2026, Zoom Communications, Inc. reported first-quarter results showing sales of US$1,239.01 million and net income of US$425.68 million, alongside new revenue guidance for the second quarter and full fiscal year 2027 and an update on its multibillion-dollar share repurchase program. The combination of higher quarterly earnings, stronger per-share profitability, and continued buybacks highlights how Zoom is using its cash generation to support both growth initiatives and capital...

Travere Therapeutics recently received a Notice of Allowance from the USPTO for a patent covering certain methods of using FILSPARI (sparsentan) to treat IgA nephropathy in the US, with protection expected to extend into October 2037 once issued and listed in the FDA’s Orange Book. This added layer of intellectual property protection around FILSPARI’s IgA nephropathy use could strengthen Travere’s competitive moat in rare kidney diseases, even as the product remains subject to strict REMS,...

Keel Infrastructure stock: recent performance snapshot Keel Infrastructure (KEEL) has drawn investor attention after a strong rebound in recent periods, with the stock up 1.1% over the past day, 18.1% over the past week, and 83.8% over the past month. See our latest analysis for Keel Infrastructure. At a share price of $5.68, Keel Infrastructure’s recent 1 month share price return of 83.82% and year to date share price return of 118.46% sit alongside a very large 1 year total shareholder...

Assessing Tarsus Pharmaceuticals after recent share price moves Tarsus Pharmaceuticals (TARS) has seen its stock give back some ground recently, with shares down about 7% over the past month and roughly 22% over the past 3 months, prompting fresh questions from investors. See our latest analysis for Tarsus Pharmaceuticals. At a recent share price of $59.40, the stock has lost momentum in the short term, with weaker 1 week, 1 month and 3 month share price returns contrasting with a much...

Why the Elyra launch matters for Becton Dickinson (BDX) shareholders Becton Dickinson (BDX) has introduced its Elyra Thulium Fiber Laser System for kidney stone care, rounding out its urologic portfolio and drawing fresh attention to how this product expansion might influence the stock. See our latest analysis for Becton Dickinson. At a share price of US$147.12, Becton Dickinson has seen its share price fall over the past quarter and year to date, while the 1 year total shareholder return...

Summit Therapeutics (SMMT) is back in focus after reporting positive overall survival data from its Phase III HARMONi-6 trial in advanced squamous NSCLC, along with strong response rates in a Phase II metastatic colorectal cancer study. See our latest analysis for Summit Therapeutics. Those new ivonescimab data arrive after a steady run in the stock, with a 90 day share price return of 16.08% and a very large 3 year total shareholder return, suggesting momentum has been building around...

If you are wondering whether Flowserve stock around its recent US$75.51 close still offers value, the next sections will walk through what the current price might be implying. The stock has delivered returns of 8.5% over the past 7 days, 5.4% over the last 30 days, 6.7% year to date, 54.9% over 1 year, 130.1% over 3 years and 92.4% over 5 years. This naturally raises questions about what is already priced in and how much risk you are taking on at this level. These moves are occurring...

J.B. Hunt Transport Services (NasdaqGS:JBHT) is being highlighted as a key physical infrastructure company tied to the rise of the AI-driven digital economy. Recent commentary and ETF allocations are pointing to JBHT as a logistics operator benefiting from investor interest in hard asset plays supporting data centers and cloud growth. The focus is shifting beyond earnings figures to the company’s freight network, trucking capacity, and intermodal infrastructure as critical pieces of the real...

In May 2026, ATRenew Inc. reported first-quarter 2026 results showing net income of CNY 135.09 million and basic earnings per share of CNY 0.56, issued second-quarter 2026 revenue guidance of RMB 6,240.0 million to RMB 6,340.0 million indicating year-over-year growth in the mid-twenties percent range, and updated progress on its share repurchase program. Ahead of extending its buyback plan by 12 months, ATRenew had already repurchased 2,320,482 shares for US$10.58 million, which can...

Earnings and Guidance Set the Stage for Agilysys Stock Agilysys (AGYS) is back in focus after reporting fourth quarter and full year results that showed higher revenue and net income year over year, along with new Fiscal 2027 guidance calling for $365 million to $370 million in revenue and at least 30% subscription growth. See our latest analysis for Agilysys. The latest earnings and Fiscal 2027 guidance appear to have shifted sentiment, with a 1 month share price return of 27.58% and a 7 day...

Why D.R. Horton (DHI) is on investors’ radar today D.R. Horton (DHI), the large US homebuilder, continues to draw attention after recent share price moves. The stock is now around $147.09 and has shown mixed returns over the past month and past 3 months. See our latest analysis for D.R. Horton. Recent moves in D.R. Horton’s share price, including a 2.34% 7 day share price gain but a share price return that is down 3.62% over 90 days, contrast with a 27.30% 1 year total shareholder return that...

Target Hospitality Corp. (NasdaqCM:TH) recently completed a secondary offering involving more than 8,000,000 shares. The shares were sold by existing shareholders, with no new capital raised for the company. The transaction led to a significant change in Target Hospitality's shareholder structure. Target Hospitality, which operates in the specialty rental and accommodation services space, now sits in a different ownership mix after this large secondary sale. Because the shares came from...

In May 2026, Prestige Consumer Healthcare’s Dramamine brand introduced two travel-friendly nausea relief options, Less Drowsy Powder stick packs and raspberry-cream Nausea Chewables, promising fast, long-lasting relief and broad retail availability at Amazon, CVS, Walgreens, and Walmart. This expansion of the Dramamine lineup deepens Prestige’s presence in over-the-counter self-care products, aligning with consumer demand for convenient, on-the-go healthcare solutions. We’ll now explore how...

In recent months, Delta Air Lines has pushed further into premium travel, expanding first-class seating, enhancing onboard meals, and rolling out more upscale lounges while leaning on loyalty partnerships to diversify revenue beyond standard economy fares. This premium focus has helped Delta generate around 20% more revenue per seat than many U.S. peers, highlighting how upselling higher-margin products can reshape an airline’s earnings mix and competitive position. Now we’ll examine how...

Recent performance snapshot and why Choice Hotels International (CHH) is on investors’ radar Choice Hotels International (CHH) has drawn attention after a mixed stretch in the stock, with the price falling about 4% over the past week but rising around 8% over the past month. See our latest analysis for Choice Hotels International. At a share price of US$108.88, Choice Hotels International has seen short term momentum cool, with a 1 day share price return down 3.95% and a 7 day share price...

Travel + Leisure (TNL) has been under pressure after Q1 results, as slightly softer EBITDA guidance outweighed in-line revenue and stronger adjusted operating income, even while the company advanced new resort projects and financing moves. See our latest analysis for Travel + Leisure. At a latest share price of US$68.00, Travel + Leisure has seen short term share price momentum soften after Q1 guidance, even though 1 year total shareholder return of 44.88% and 3 year total shareholder return...

On May 18, 2026, EVERTEC, Inc. entered a sixth amendment to its 2022 Credit Agreement, securing an additional US$185 million Term Loan B that was used to repay borrowings under its revolving facility, bringing total Term B Loans outstanding to US$875 million. On the same day, EVERTEC announced a new agreement under which it will operate key transaction platforms and services for Chile’s Transbank, deepening its role as a technology provider across Latin America. We’ll now examine how running...

In May 2026, Kimberly-Clark’s Pull-Ups brand introduced new Learning Layer technology in its training pants, briefly creating a wet sensation before drying to help toddlers distinguish between wet and dry while remaining safe for sensitive skin. This upgrade, combined with existing features like re-fastenable sides and Disney graphics plus expanded use of animated characters Terd and Yureen, signals a push to deepen parent engagement at a critical early childhood stage. We’ll now examine how...

In recent weeks, Strategy Inc. has drawn attention with its first major Bitcoin transfer to Coinbase Prime in nearly two years, large debt repurchases, and expanded preferred stock issuance to fund additional Bitcoin purchases. These moves have intensified debate over whether Strategy’s heavily Bitcoin-backed capital structure can comfortably support rising preferred dividends and liquidity needs without altering its long-held "never sell" posture. We’ll now examine how growing questions...

Meta Platforms (META) has kicked off a new chapter for its stock with the rollout of paid subscriptions across Instagram, Facebook, WhatsApp and Meta AI under the Meta One banner. See our latest analysis for Meta Platforms. The Meta One launch lands at a time when the share price is US$632.51, with the stock up 3.9% on a 30 day share price return but down 3.45% over 90 days. The 3 year total shareholder return of 134.89% contrasts with a 1 year total shareholder return that has declined...

Recent share performance and business profile Karman Holdings (KRMN) has drawn investor attention after the stock declined about 13% over the past month and roughly 37% over the past 3 months, leaving shares at US$57.50 at the last close. See our latest analysis for Karman Holdings. That recent slide fits into a wider reset in momentum, with the share price return down 25% year to date and 37% over 3 months, even though the 1 year total shareholder return is 30%. If this kind of volatility...

The FDA enforcement report on a software defect in several Dexcom (DXCM) CGM iOS and watchOS apps has pushed product reliability and recall risk to the foreground for DexCom stock investors. See our latest analysis for DexCom. Despite the recall related to its CGM apps, DexCom's recent trading has been relatively resilient, with a 1 month share price return of 20.2% and a year to date share price return of 10.82%. However, the 1 year total shareholder return is down 13.76%, suggesting that...

Recent commentary has spotlighted PDF Solutions (PDFS) as a momentum stock, pointing to upward earnings estimate revisions and a favorable momentum score as signs of growing investor interest in the Santa Clara based software provider. See our latest analysis for PDF Solutions. At a share price of US$48.83, PDF Solutions has logged a 90 day share price return of 49.10% and a 1 year total shareholder return of 174.02%, indicating momentum that has built steadily rather than in a short...